With increasing scrutiny from regulatory bodies and a rising tide of product recalls, companies must choose between two approaches: the carrot, which symbolises incentives for quality improvement, and the stick, representing punitive measures for non-compliance. NSF experts look at the historical context, current challenges, and potential pathways for the pharma biotech sector to prioritise quality, ultimately benefiting both businesses and consumers.
The carrot and the stick: revitalising quality in the pharmaceutical industry
The pharmaceutical sector is at a critical juncture, facing immense pressure to enhance quality management systems and ensure the safety of medications
